- Home
- AMTD vs INZY Comparison
AMTD vs INZY Comparison
Compare AMTD & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTD
- INZY
- Stock Information
- Founded
- AMTD 2003
- INZY 2015
- Country
- AMTD France
- INZY United States
- Employees
- AMTD N/A
- INZY N/A
- Industry
- AMTD
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- AMTD
- INZY Health Care
- Exchange
- AMTD Nasdaq
- INZY Nasdaq
- Market Cap
- AMTD 67.4M
- INZY 64.9M
- IPO Year
- AMTD 2019
- INZY 2020
- Fundamental
- Price
- AMTD $1.00
- INZY $1.15
- Analyst Decision
- AMTD
- INZY Strong Buy
- Analyst Count
- AMTD 0
- INZY 9
- Target Price
- AMTD N/A
- INZY $17.22
- AVG Volume (30 Days)
- AMTD 10.3K
- INZY 1.1M
- Earning Date
- AMTD 05-16-2025
- INZY 05-20-2025
- Dividend Yield
- AMTD N/A
- INZY N/A
- EPS Growth
- AMTD N/A
- INZY N/A
- EPS
- AMTD 0.76
- INZY N/A
- Revenue
- AMTD $67,032,000.00
- INZY N/A
- Revenue This Year
- AMTD N/A
- INZY N/A
- Revenue Next Year
- AMTD N/A
- INZY N/A
- P/E Ratio
- AMTD $1.31
- INZY N/A
- Revenue Growth
- AMTD N/A
- INZY N/A
- 52 Week Low
- AMTD $0.95
- INZY $0.72
- 52 Week High
- AMTD $1.97
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- AMTD 45.05
- INZY 50.96
- Support Level
- AMTD $0.99
- INZY $1.18
- Resistance Level
- AMTD $1.04
- INZY $1.63
- Average True Range (ATR)
- AMTD 0.03
- INZY 0.20
- MACD
- AMTD 0.00
- INZY 0.02
- Stochastic Oscillator
- AMTD 28.57
- INZY 23.66
About AMTD AMTD IDEA Group each representing six (6)
AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.